| Peer-Reviewed

Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria

Received: 10 January 2023     Accepted: 2 February 2023     Published: 16 February 2023
Views:       Downloads:
Abstract

Background: The burden of foot ulceration and amputation among persons living with diabetes mellitus is quite huge and peripheral neuropathy is a well known risk factor for this. The prevalence of peripheral neuropathy and associated factors among persons living with diabetes, using an objective assessment (biothesiometer), is unknown in our study environment. Method: This was a cross-sectional study involving 108 age matched diabetes mellitus patients and controls. The study was conducted in the Diabetes Clinic of the University of Uyo Teaching Hospital, in Southern Nigeria. Basic demographics and other parameters such as duration of diabetes and glycated haemoglobin were recorded. All participants were recruited consecutively and screened for vibration perception threshold (VPT) using a biothesiometer. Participants with VPT ≥ 25 were considered to have significant neuropathy. Results: Significant neuropathy was recorded in 18 (33.3%) of the 54 diabetes patients. Only 3 (5.5%) of the 54 controls had significant neuropathy (p<0.01). The diabetes patients with significant neuropathy had a mean HbA1c of 8.9% compared to 7.3% for diabetes patients without significant neuropathy (p=0.02). The mean age of the diabetes patients with peripheral neuropathy was 54.0±2.3 years compared to 48.3±1.9 years for the diabetes patients without peripheral neuropathy (p<0.01). The mean duration of diabetes among diabetes patients with significant neuropathy was 10.3 years compared to 6.7 years for diabetes patients without significant neuropathy (p=0.01). Conclusion: There is a high prevalence of significant peripheral neuropathy among diabetes patients as determined using a biothesiometer. Early detection and achieving a good glycaemic control may help in reducing this burden which exposes the patients to the risk of possible amputation, depression and even death.

Published in International Journal of Diabetes and Endocrinology (Volume 8, Issue 1)
DOI 10.11648/j.ijde.20230801.12
Page(s) 6-11
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Biothesiometer, Assessment, Diabetes Mellitus, Uyo, Nigeria

References
[1] Sun H, Saeedi P, Karuranga S, Pinkepork M, Ogurtsova K, Duncan BB et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Prat 2022.
[2] Kelkar P. Diabetic neuropathy. Semin Neurol. 2005; 25 (2): 168–173. doi: 10.1055/s-2005-871325.
[3] Zanni GR, Wick JY. Understanding amputation. Consult Pharm 2008; 23 (12): 944 8.
[4] Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. (2018) 40: 828–49. doi: 10.1016
[5] BMK Aruna et al. Role of Biothesiometry in the diagnosis of diabetic neuropathy. Indian Journal of Clinical Anatomy and Physiology, July-September, 2017; 4 (3): 329-331.
[6] Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008 Nov; 88 (11): 1254-64. doi: 10.2522/ptj.20080020. Epub 2008 Sep 18. PMID: 18801858; PMCID: PMC3870323.
[7] Oguejiofor OC, Onwukwe CH, Ezeude CM, Okonkwo EK, Nwalozie JC, Odenigbo CU, Oguejiofor CB. Peripheral neuropathy and its clinical correlates in Type 2 diabetic subjects without neuropathic symptoms in Nnewi, South-Eastern Nigeria. J Diabetol 2019; 10: 21-4.
[8] Ogbera AO, Adeleye O, Solagberu B, Azenabor A. Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital. BMC Res Notes. 2015 Oct 4; 8: 533. doi: 10.1186/s13104-015-1423-2. PMID: 26435536; PMCID: PMC4592746.
[9] Ugoya SO, Ugoya TA, Puepet F, Agaba EI, Ogunniyi AO. Risk determinants of diabetic peripheral neuropathy in Jos, North central Nigeria J Chin Clin Med. 2008; 3: 285–91.
[10] Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med. 2014 Jul-Sep; 60 (3): 270-5. doi: 10.4103/0022-3859.138750. PMID: 25121366.
[11] Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, Ravikiran M. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011 Jun; 133 (6): 645-9. PMID: 21727664; PMCID: PMC3135993.
[12] Cameron NE, Eaton SE, Cotter MA, et al.: Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001; 44 (11): 1973–88.
[13] Tesfaye S, Selvarajah D: Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012; 28 (Suppl 1): 8–14.
[14] Singh R, Kishore L, Kaur N: Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res. 2014; 80: 21–35. 10.1016/j.phrs.2013.12.005
[15] Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: A meta-analysis. PLoS One. 2019 Feb 20; 14 (2): e0212574. doi: 10.1371/journal.pone.0212574. PMID: 30785930; PMCID: PMC6382168.
[16] Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018 Feb 21; 10: 8. doi: 10.1186/s13098-018-0309-6. Erratum in: Diabetol Metab Syndr. 2018 May 18; 10: 43. PMID: 29483946; PMCID: PMC5822644.
[17] Oguejiofor OC, Odenigbo CU, Oguejiofor CB. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010; 13 (3): 240–247.
[18] Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. (2004) 127: 1593–605. doi: 10.1093/brain/awh180
[19] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. (1998) 352: 837–53. doi: 10.1016/S0140-6736(98)07019-
[20] Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. (2010) 376: 419–30. doi: 10.1016/S0140-6736(10)60576-4
[21] Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012: Cd007543. doi: 10.1002/14651858.CD007543.pub2
[22] Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diabetes Rep. (2014) 14: 528. doi: 10.1007/s11892-014-0528-7
[23] Malik RA. Why are there no good treatments for diabetic neuropathy? Lancet Diabetes.
[24] Saber, Hemin Jawad1; Daoud, Ali Shakir2. Knowledge and practice about the foot care and the prevalence of the neuropathy among a sample of type 2 diabetic patients in Erbil, Iraq. Journal of Family Medicine and Primary Care 7 (5): p 967-974, Sep–Oct 2018. | DOI: 10.4103/jfmpc.jfmpc_163_18
[25] George H, Rakesh P, Krishna M, Alex R, Abraham VJ, George K, Prasad JH. Foot care knowledge and practices and the prevalence of peripheral neuropathy among people with diabetes attending a secondary care rural hospital in southern India. J Family Med Prim Care. 2013 Jan; 2 (1): 27-32. doi: 10.4103/2249-4863.109938. PMID: 24479039; PMCID: PMC3894008.
[26] Adeyemi TM, Olatunji TL, Adetunji AE, Rehal S. Knowledge, Practice and Attitude towards Foot Ulcers and Foot Care among Adults Living with Diabetes in Tobago: A Qualitative Study. Int J Environ Res Public Health. 2021 Jul 29; 18 (15): 8021. doi: 10.3390/ijerph18158021. PMID: 34360314; PMCID: PMC8345419.
Cite This Article
  • APA Style

    Onung Samuel, Akhimienho Kingsley, Amadi Collins, Anyiekere Ekanem, Umoren Ubong, et al. (2023). Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria. International Journal of Diabetes and Endocrinology, 8(1), 6-11. https://doi.org/10.11648/j.ijde.20230801.12

    Copy | Download

    ACS Style

    Onung Samuel; Akhimienho Kingsley; Amadi Collins; Anyiekere Ekanem; Umoren Ubong, et al. Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria. Int. J. Diabetes Endocrinol. 2023, 8(1), 6-11. doi: 10.11648/j.ijde.20230801.12

    Copy | Download

    AMA Style

    Onung Samuel, Akhimienho Kingsley, Amadi Collins, Anyiekere Ekanem, Umoren Ubong, et al. Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria. Int J Diabetes Endocrinol. 2023;8(1):6-11. doi: 10.11648/j.ijde.20230801.12

    Copy | Download

  • @article{10.11648/j.ijde.20230801.12,
      author = {Onung Samuel and Akhimienho Kingsley and Amadi Collins and Anyiekere Ekanem and Umoren Ubong and Ekuma Ikwo and Asukpong Eso},
      title = {Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria},
      journal = {International Journal of Diabetes and Endocrinology},
      volume = {8},
      number = {1},
      pages = {6-11},
      doi = {10.11648/j.ijde.20230801.12},
      url = {https://doi.org/10.11648/j.ijde.20230801.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20230801.12},
      abstract = {Background: The burden of foot ulceration and amputation among persons living with diabetes mellitus is quite huge and peripheral neuropathy is a well known risk factor for this. The prevalence of peripheral neuropathy and associated factors among persons living with diabetes, using an objective assessment (biothesiometer), is unknown in our study environment. Method: This was a cross-sectional study involving 108 age matched diabetes mellitus patients and controls. The study was conducted in the Diabetes Clinic of the University of Uyo Teaching Hospital, in Southern Nigeria. Basic demographics and other parameters such as duration of diabetes and glycated haemoglobin were recorded. All participants were recruited consecutively and screened for vibration perception threshold (VPT) using a biothesiometer. Participants with VPT ≥ 25 were considered to have significant neuropathy. Results: Significant neuropathy was recorded in 18 (33.3%) of the 54 diabetes patients. Only 3 (5.5%) of the 54 controls had significant neuropathy (p<0.01). The diabetes patients with significant neuropathy had a mean HbA1c of 8.9% compared to 7.3% for diabetes patients without significant neuropathy (p=0.02). The mean age of the diabetes patients with peripheral neuropathy was 54.0±2.3 years compared to 48.3±1.9 years for the diabetes patients without peripheral neuropathy (p<0.01). The mean duration of diabetes among diabetes patients with significant neuropathy was 10.3 years compared to 6.7 years for diabetes patients without significant neuropathy (p=0.01). Conclusion: There is a high prevalence of significant peripheral neuropathy among diabetes patients as determined using a biothesiometer. Early detection and achieving a good glycaemic control may help in reducing this burden which exposes the patients to the risk of possible amputation, depression and even death.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria
    AU  - Onung Samuel
    AU  - Akhimienho Kingsley
    AU  - Amadi Collins
    AU  - Anyiekere Ekanem
    AU  - Umoren Ubong
    AU  - Ekuma Ikwo
    AU  - Asukpong Eso
    Y1  - 2023/02/16
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijde.20230801.12
    DO  - 10.11648/j.ijde.20230801.12
    T2  - International Journal of Diabetes and Endocrinology
    JF  - International Journal of Diabetes and Endocrinology
    JO  - International Journal of Diabetes and Endocrinology
    SP  - 6
    EP  - 11
    PB  - Science Publishing Group
    SN  - 2640-1371
    UR  - https://doi.org/10.11648/j.ijde.20230801.12
    AB  - Background: The burden of foot ulceration and amputation among persons living with diabetes mellitus is quite huge and peripheral neuropathy is a well known risk factor for this. The prevalence of peripheral neuropathy and associated factors among persons living with diabetes, using an objective assessment (biothesiometer), is unknown in our study environment. Method: This was a cross-sectional study involving 108 age matched diabetes mellitus patients and controls. The study was conducted in the Diabetes Clinic of the University of Uyo Teaching Hospital, in Southern Nigeria. Basic demographics and other parameters such as duration of diabetes and glycated haemoglobin were recorded. All participants were recruited consecutively and screened for vibration perception threshold (VPT) using a biothesiometer. Participants with VPT ≥ 25 were considered to have significant neuropathy. Results: Significant neuropathy was recorded in 18 (33.3%) of the 54 diabetes patients. Only 3 (5.5%) of the 54 controls had significant neuropathy (p<0.01). The diabetes patients with significant neuropathy had a mean HbA1c of 8.9% compared to 7.3% for diabetes patients without significant neuropathy (p=0.02). The mean age of the diabetes patients with peripheral neuropathy was 54.0±2.3 years compared to 48.3±1.9 years for the diabetes patients without peripheral neuropathy (p<0.01). The mean duration of diabetes among diabetes patients with significant neuropathy was 10.3 years compared to 6.7 years for diabetes patients without significant neuropathy (p=0.01). Conclusion: There is a high prevalence of significant peripheral neuropathy among diabetes patients as determined using a biothesiometer. Early detection and achieving a good glycaemic control may help in reducing this burden which exposes the patients to the risk of possible amputation, depression and even death.
    VL  - 8
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Endocrinology, Diabetes and Metabolism Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Department of Paediatrics, Edo State University, Uzairue, Nigeria

  • Department of Chemical Pathology, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Department of Community Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Endocrinology, Diabetes and Metabolism Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Endocrinology, Diabetes and Metabolism Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Endocrinology, Diabetes and Metabolism Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria

  • Sections